Il y a eu 23 transactions d'initiés récentes enregistrées pour Heartflow, Inc. Common Stock (HTFL), dont 5 achats et 18 ventes. Le total des achats d'initiés s'élève à $13.33M et le total des ventes d'initiés à $59.84M.
Les initiés notables ayant une activité récente comprennent Rogers Campbell, Healthcor Partners Management Lp, Lightcap Jeffrey C. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — HTFL
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-01 |
Rogers Campbell |
Chief Medical Officer |
Exercice d'Options (Vente) |
6,849 |
$2.22 |
$15.2K |
- |
| 2026-03-24 |
Healthcor Partners Management Lp |
Director |
Autre (Vente) |
4,615,542 |
- |
- |
- |
| 2026-03-24 |
Lightcap Jeffrey C |
Director |
Autre (Achat) |
206,261 |
- |
- |
246,261 |
| 2026-03-19 |
Rogers Campbell |
Chief Medical Officer |
Vente Informative |
64,533 |
$25.69 |
$1.66M |
78,518 |
| 2026-03-18 |
Farquhar John C.m. |
Chief Executive Officer |
Vente Informative |
9,725 |
$25.00 |
$243.13K |
571,725 |
| 2026-03-11 |
Barabe Timothy C |
Director |
Exercice d'Options (Vente) |
8,667 |
$2.22 |
$19.24K |
15,412 |
| 2026-03-10 |
Farquhar John C.m. |
Chief Executive Officer |
Vente Informative |
12,837 |
$22.66 |
$290.89K |
581,450 |
| 2026-03-06 |
Farquhar John C.m. |
Chief Executive Officer |
Attribution de RSU |
2,631 |
$16.15 |
$42.49K |
594,287 |
| 2026-03-05 |
Cullivan Julie A |
Director |
Vente Informative |
9,122 |
$25.00 |
$228.05K |
27,291 |
| 2026-02-17 |
Barabe Timothy C |
Director |
Exercice d'Options (Vente) |
2,497 |
$8.33 |
$20.8K |
- |
| 2026-02-12 |
Rogers Campbell |
Chief Medical Officer |
Exercice d'Options (Vente) |
39,709 |
$8.33 |
$330.78K |
- |
| 2026-02-10 |
Farquhar John C.m. |
Chief Executive Officer |
Vente Informative |
22,562 |
$27.46 |
$619.55K |
591,656 |
| 2026-02-06 |
Rogers Campbell |
Chief Medical Officer |
Retenue Fiscale RSU |
515 |
$27.74 |
$14.29K |
20,098 |
| 2026-02-06 |
Farquhar John C.m. |
Chief Executive Officer |
Attribution de RSU |
321,259 |
$27.74 |
$8.91M |
321,259 |
| 2026-02-06 |
Jones Marie L. |
Chief Accounting Officer, VP |
Retenue Fiscale RSU |
94 |
$27.74 |
$2.61K |
10,021 |
| 2026-02-06 |
Verghese Vikram |
Chief Financial Officer |
Attribution de RSU |
119,685 |
$27.74 |
$3.32M |
119,685 |
| 2026-02-05 |
Cullivan Julie A |
Director |
Vente Informative |
8,000 |
$27.32 |
$218.56K |
36,413 |
| 2026-02-04 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Vente Informative |
2,000,000 |
$28.05 |
$56.1M |
10,448,158 |
| 2025-12-16 |
Lightcap Jeffrey C |
Director |
Achat Informatif |
40,000 |
$26.34 |
$1.05M |
40,000 |
| 2025-11-07 |
Rogers Campbell |
Chief Medical Officer |
Retenue Fiscale RSU |
439 |
$32.56 |
$14.29K |
20,613 |
| 2025-11-07 |
Farquhar John C.m. |
Chief Executive Officer |
Retenue Fiscale RSU |
1,339 |
$32.56 |
$43.6K |
431,909 |
| 2025-11-07 |
Jones Marie L. |
Chief Accounting Officer, VP |
Retenue Fiscale RSU |
81 |
$32.56 |
$2.64K |
10,115 |
| 2025-11-07 |
Verghese Vikram |
Chief Financial Officer |
Retenue Fiscale RSU |
471 |
$32.56 |
$15.34K |
144,912 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
